PLERIXAFOR β EUGIA PHARMA, approved 2025-03-26 (ANDA213672).
1,124 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.